Abstract
Cardiovascular diseases (CVD) are complex disorders involving the impaired function of blood vessels or the heart. Several risk factors contribute to CVD, including diet, body composition and physical activity. We developed an interpretable machine learning model integrating nongenetic factors from 502,134 UK Biobank participants, of whom 53,378 experienced a CVD event over eighteen years of follow-up. Age, cystatin C, and self-perceived health status emerged as the most relevant predictors of CVD. By combining these variables into a multidimensional model, we achieved excellent predictive performance, with an area under the ROC curve of 0.99 and both sensitivity and specificity above 0.97 in the validation cohort. Although cardiovascular events arise from multiple factors, our results show that data integration and machine learning can accurately predict individual risk using simple measurements. This approach could also support the prediction of other cardiovascular outcomes and aid personalized risk assessment and preventive care.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
The UK Biobank was supported by the Wellcome Trust, Medical Research Council, Department of Health, Scottish Government, the Northwest Regional Development Agency, the Welsh Assembly Government and the British Heart Foundation. This research has been conducted using the UK Biobank resource under application number 124330. H. P.S. and C. M.-C. acknowledge funding by the European Project Horizon 2020 SC1-BHC-02-2019 [RE-VERT, ID: 848098]. C.P. is funded by RYC2020-028818-I (MCIN/AEI/10.13039/501100011033 and ESF Investing in your future, Ministry of Science and Innovation, Spain), which also paid for the access to the data. This research was designed, conducted, analysed, and interpreted by the authors entirely independently of the funding sources.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
https://www.ukbiobank.ac.uk/about-our-data/
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Footnotes
↵* Joint senior authors
